TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 70 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,612,000 | +163.0% | 21,424 | -6.2% | 0.01% | +266.7% |
| Q1 2022 | $613,000 | -47.4% | 22,830 | -6.6% | 0.00% | -50.0% |
| Q4 2021 | $1,166,000 | -30.3% | 24,437 | -2.9% | 0.01% | -33.3% |
| Q3 2021 | $1,672,000 | -16.8% | 25,167 | -2.3% | 0.01% | +28.6% |
| Q2 2021 | $2,010,000 | -2.3% | 25,765 | +18.4% | 0.01% | 0.0% |
| Q1 2021 | $2,058,000 | -22.2% | 21,761 | +0.3% | 0.01% | -30.0% |
| Q4 2020 | $2,645,000 | +48.3% | 21,704 | +6.3% | 0.01% | +11.1% |
| Q3 2020 | $1,784,000 | +62.2% | 20,418 | +19.9% | 0.01% | +80.0% |
| Q2 2020 | $1,100,000 | +50.3% | 17,029 | +3.9% | 0.01% | +25.0% |
| Q1 2020 | $732,000 | -32.2% | 16,395 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $1,080,000 | +583.5% | 17,342 | +313.6% | 0.00% | +300.0% |
| Q3 2019 | $158,000 | -8.1% | 4,193 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $172,000 | – | 4,223 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 3,037,042 | $236,950,000 | 8.05% |
| MPM BioImpact LLC | 269,186 | $21,002,000 | 3.45% |
| Logos Global Management LP | 400,000 | $31,208,000 | 2.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 121,541 | $9,481,000 | 2.50% |
| Orbimed Advisors | 2,361,327 | $184,231,000 | 1.86% |
| First Light Asset Management, LLC | 395,825 | $30,882,000 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 211,650 | $16,513,000 | 1.34% |
| Nicholas Investment Partners, LP | 224,876 | $17,545,000 | 1.10% |
| DAFNA Capital Management LLC | 47,852 | $3,733,000 | 0.78% |
| Eventide Asset Management | 578,000 | $45,096,000 | 0.61% |